Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.08 0.00 (-0.24%)
As of: Oct 22, 2026 · 3:31 PM EDT

Black Diamond Therapeutics (BDTX) Non Operating Interest Expenses (2020)

Updated

Black Diamond Therapeutics (BDTX) reported Non Operating Interest Expenses of $1,000 for FY2020.

Analysis

Black Diamond Therapeutics (BDTX) Non Operating Interest Expenses (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,169.70 Bn 1,138.29 Bn 19.71 Bn -
2 Johnson & Johnson 647.50 Bn 567.36 Bn 17.30 Bn 217.00 Mn
3 AbbVie 504.26 Bn 477.37 Bn 12.70 Bn -
4 Merck 368.38 Bn 322.75 Bn 12.21 Bn -
5 Novartis Ag 303.14 Bn 267.13 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 268.24 Bn 241.93 Bn 12.86 Bn 435.00 Mn
7 Amgen 242.50 Bn 197.90 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn 247.00 Mn
9 Pfizer 173.14 Bn 119.78 Bn 10.94 Bn -
10 Black Diamond Therapeutics 119.04 Mn -373.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 1,000.00
API Access

Black Diamond Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=BDTX&period=max&api_key=YOUR_API_KEY